Albion Financial Group’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $30K | Buy |
+175
| New | +$30K | ﹤0.01% | 285 |
|
|
2019
Q3 | – | Sell |
-9,597
| Closed | -$1.24M | – | 208 |
|
|
2019
Q2 | $1.24M | Sell |
9,597
-417
| -4% | -$53.8K | 0.16% | 88 |
|
|
2019
Q1 | $1.29M | Sell |
10,014
-145
| -1% | -$18.6K | 0.17% | 85 |
|
|
2018
Q4 | $1.13M | Sell |
10,159
-279
| -3% | -$30.9K | 0.18% | 86 |
|
|
2018
Q3 | $1.42M | Sell |
10,438
-326
| -3% | -$44.3K | 0.19% | 80 |
|
|
2018
Q2 | $1.29M | Sell |
10,764
-304
| -3% | -$36.5K | 0.19% | 83 |
|
|
2018
Q1 | $1.33M | Sell |
11,068
-196
| -2% | -$23.6K | 0.2% | 78 |
|
|
2017
Q4 | $1.4M | Sell |
11,264
-644
| -5% | -$80.3K | 0.21% | 78 |
|
|
2017
Q3 | $1.6M | Sell |
11,908
-343
| -3% | -$46K | 0.24% | 69 |
|
|
2017
Q2 | $1.54M | Sell |
12,251
-593
| -5% | -$74.5K | 0.26% | 65 |
|
|
2017
Q1 | $1.53M | Sell |
12,844
-1,182
| -8% | -$141K | 0.23% | 65 |
|
|
2016
Q4 | $1.51M | Buy |
14,026
+702
| +5% | +$75.5K | 0.25% | 66 |
|
|
2016
Q3 | $1.54M | Buy |
13,324
+778
| +6% | +$89.6K | 0.26% | 67 |
|
|
2016
Q2 | $1.28M | Sell |
12,546
-194
| -2% | -$19.9K | 0.23% | 60 |
|
|
2016
Q1 | $1.32M | Sell |
12,740
-28
| -0.2% | -$2.9K | 0.22% | 60 |
|
|
2015
Q4 | $1.62M | Buy |
12,768
+179
| +1% | +$22.7K | 0.28% | 48 |
|
|
2015
Q3 | $1.44M | Sell |
12,589
-781
| -6% | -$89.3K | 0.26% | 53 |
|
|
2015
Q2 | $1.8M | Sell |
13,370
-174
| -1% | -$23.5K | 0.3% | 46 |
|
|
2015
Q1 | $1.76M | Sell |
13,544
-1,186
| -8% | -$154K | 0.3% | 43 |
|
|
2014
Q4 | $1.7M | Sell |
14,730
-11,582
| -44% | -$1.34M | 0.29% | 44 |
|
|
2014
Q3 | $2.79M | Buy |
26,312
+1,920
| +8% | +$203K | 0.49% | 34 |
|
|
2014
Q2 | $2.33M | Buy |
24,392
+889
| +4% | +$84.8K | 0.4% | 43 |
|
|
2014
Q1 | $2.14M | Buy |
23,503
+1,226
| +6% | +$111K | 0.39% | 45 |
|
|
2013
Q4 | $1.97M | Sell |
22,277
-321
| -1% | -$28.4K | 0.37% | 45 |
|
|
2013
Q3 | $1.87M | Buy |
22,598
+708
| +3% | +$58.6K | 0.4% | 43 |
|
|
2013
Q2 | $1.5M | Buy |
+21,890
| New | +$1.5M | 0.33% | 45 |
|